Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 15/20 | 0.54 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | DRD3 | P35462 | 2/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 12/20 | 0.46 |
| ▸ | DRD2 | P14416 | 5/20 | 0.46 |
| ▸ | HTR6 | P50406 | 5/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6795245 | 0.93 | HTR1A (0.53) | HTR1AHTR2ADRD3HTR2CHTR7 | |
| SCHEMBL7723383 | 0.89 | HTR1A (0.53) | HTR1AHTR2ADRD3HTR2CHTR7 | |
| SCHEMBL6770007 | 0.88 | SLC6A2 (0.49) | HTR1AHTR2ADRD3HTR2CHTR7 | |
| SCHEMBL7118283 | 0.86 | DRD3 (0.55) | HTR1AHTR2ADRD3HTR2C | |
| SCHEMBL6770740 | 0.86 | HTR1A (0.49) | HTR1AHTR2ADRD3HTR7DRD2 | |
| SCHEMBL6793155 | 0.85 | MTTP (0.47) | HTR1AHTR2ADRD3HTR2C | |
| SCHEMBL6771329 | 0.83 | ALDH1A1 (0.49) | HTR1AHTR7DRD2HTR6 | |
| SCHEMBL6769811 | 0.82 | DRD3 (0.51) | HTR1AHTR2ADRD3HTR2CDRD2 | |
| SCHEMBL6793499 | 0.82 | HTR1A (0.51) | HTR1AHTR2ADRD3HTR2CHTR7 | |
| SCHEMBL6769569 | 0.82 | RAB9A (0.55) | HTR1AHTR7DRD2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6818644-B1 | FLUORENE-9-CARBOXYLIC AMIDES; INHIBITORS OF MICROSOMAL TRIGLYSERIDE-TRANSFER PROTEIN (MTP); ANTILIPEMIC AGENTS; ATHEROSCLEROSIS, DIABETES, EATING DISORDERS, AND PANCREATITIS | BOEHRINGER INGELHEIM PHARM GMBH & CO, KG (DE) | 2004-11-16 | — | — | US | disclosed |